Alpheus Medical Starts Phase 2b Trial in Glioblastoma
CHANHASSEN, Minnesota, April 9, 2026 Alpheus Medical, Inc. has announced the initiation of its Phase 2b randomized clinical trial...
Phase 2b trial
Advertisement
Insmed CEDAR Study Misses Endpoints in HS Trial
BRIDGEWATER, N.J., April 7, 2026 Insmed Incorporated has announced that its Phase 2b CEDAR clinical trial evaluating brensocatib in...
Glycomine Advances GLM101 Into Phase 2b Rare Disease Trial
SAN CARLOS, Calif., April 2, 2026 Glycomine, Inc. has announced the successful completion of patient enrollment in its global...
Deupirfenidone Shows Strong IPF Results in Phase 2b Study
NEW YORK, April 2, 2026 PureTech Health plc has announced the publication of its Phase 2b ELEVATE IPF trial...
Rezpegaldesleukin Shows Strong Phase 2b Results in AD
San Francisco, USA | March 28, 2026 Phase 2b Data Demonstrates Strong Clinical Efficacy Nektar Therapeutics has announced compelling...
Advertisements
GH Research GH001 Shows Strong TRD Clinical Results
DUBLIN, Ireland, March 25, 2026 GH Research has announced the peer-reviewed publication of Phase 2b clinical results for GH001...
NeuroSense Reports Positive Phase 2b PrimeC ALS Results
Cambridge, Massachusetts, March 16, 2026 NeuroSense Therapeutics Ltd. announced the publication of results from its PARADIGM Phase 2b clinical...
FDA Clears MRM Health’s Phase 2b Microbiome Trial in UC
GHENT, Belgium | January 9, 2026 — MRM Health announced that the U.S. Food and Drug Administration (FDA) has...
Vicore Pharma Advances to Nasdaq Mid Cap Segment
Stockholm, Sweden, December 19, 2025 — Vicore Pharma Holding AB (publ) announced that it will move from the Nasdaq...
Advertisement
